← back to search

Rohit Bhattacharya

Williams College · US
Area of research
Immunology · Statistics and Probability
Research interest
Research interests include Immunotherapy and Immune Responses, Advanced Causal Inference Techniques, Bayesian Modeling and Causal Inference, and Monoclonal and Polyclonal Antibodies Research.
h-index
13
citations
2,393
works
76
NIH funding
primary concept
email

Recent publications

Abstract A33: High-throughput prediction of MHC Class I and Class II neoantigens with MHCnuggets
Cancer Immunology Research 2020cited by 0position: middledoi
High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets
Cancer Immunology Research 2019cited by 195position: middledoi
High-throughput prediction of MHC Class I and Class II neoantigens with MHCnuggets
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 5position: middledoi
High grade serous ovarian carcinomas originate in the fallopian tube
Nature Communications 2017cited by 752position: middledoi
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Cancer Discovery 2016cited by 893position: middledoi
Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure
Cancer Research 2016cited by 140position: middledoi

Grants

CRII: RI: RUI: Robust Causal Inference Under Model Misspecification And Uncertainty
NSF2348287$174,1182024–2027PIRePORTER

Frequent collaborators

Collin Tokheim · Johns Hopkins University4 papers (2016–2020)Rachel Karchin · University of Baltimore4 papers (2016–2020)Ashton Omdahl · Johns Hopkins Medicine3 papers (2019–2020)Valsamo Anagnostou · Cornell University3 papers (2019–2020)Justin Huang · The First Affiliated Hospital, Sun Yat-sen University3 papers (2019–2020)Maria Bonsack · German Cancer Research Center3 papers (2019–2020)I.K. Ashok Sivakumar · Johns Hopkins University2 papers (2019–2019)Xiaoshan M. Shao · Johns Hopkins Medicine2 papers (2019–2020)Dylan Hirsch · Johns Hopkins Medicine2 papers (2019–2020)Lily Zheng · Center for Drug Evaluation and Research2 papers (2019–2020)Angelika B. Riemer · German Cancer Research Center2 papers (2019–2020)Victor E. Velculescu · Sidney Kimmel Cancer Center2 papers (2019–2020)Benjamin Kaminow · Memorial Sloan Kettering Cancer Center2 papers (2019–2019)Kymberleigh A. Pagel · Directorate-General for Interpretation2 papers (2019–2020)David L. Masica · AbbVie (United States)1 papers (2016–2016) · 1 papers (2020–2020) · 1 papers (2020–2020)Rick Kim · University of California, Santa Cruz1 papers (2016–2016)Michael T. Ryan · Australian Regenerative Medicine Institute1 papers (2016–2016)Noushin Niknafs · Johns Hopkins University1 papers (2016–2016)